Editorial Board
Editors-in-Chief
- Dr Franco M Buonaguro Istituto Nazionale Tumori, Naples, Italy
- Dr Sam M Mbulaiteye National Cancer Institute, Bethesda, United States
Managing Editor
- Dr Maria Lina Tornesello National Cancer Institute Fond Pascale, Italy
Section Editors
- Prof Serigne Magueye Gueye General hospital of Grand-Yoff, Senegal
- Prof Twalib Ngoma Ocean Road Cancer Institute, Tanzania
- Prof Jan Vermorken University Hospital Antwerp, Belgium
- Prof Henry Wabinga Makerere University, Uganda
Editorial Board
- Prof Niyaz Ahmed University of Hyderabad, India
- Dr Adriana Albini IRCCS Multimedica, Italy
- Prof Richard Ambinder John Hopkins University, United States
- Prof Charles Bangham Imperial College London, United Kingdom
- Dr Filippo Belardelli Istituto Superiore di Sanità , Italy
- Prof Valerie Beral University of Oxford, United Kingdom
- Prof Hans-Ulrich Bernard University of California, Irvine, United States
- Prof Luigi Buonaguro Istituto Nazionale Tumori, Italy
- Prof Arséne Burny University of Brussels, Belgium
- Prof Yuan Chang University of Pittsburgh Cancer Institute, United States
- Prof Massimo Clementi Vita-Salute San Raffaele University, Italy
- Prof Pierre Coursaget Faculty of Pharmacy, INSERM, France
- Prof Ethel-Michele de Villiers German Cancer Research Center, Germany
- Prof Manfred P. Dierich Univeristät Innsbruck, Austria
- Dr Riccardo Dolcetti Centro di Riferimento Oncologico, Italy
- Prof Volker Erfle Institute for Molecular Virology, Germany
- Prof Reza Farid University of Mashhad, Iran
- Dr Silvia Franceschi International Agency for Research on Cancer, France
- Prof Niza Frenkel Tel Aviv University, Israel
- Denise Galloway Fred Hutchinson Cancer Research Center, United States
- Prof Bin Gao Chinese Academy of Sciences, China
- Dr Michie Hisada Viral Epidemiology Branch, National Institutes of Health, United States
- Dr Jean Marie Houghton University of Massachusetts, United States
- Prof Shuji IZUMO Kagoshima University, Japan
- Dr Steven Jacobson Viral Immunology Section, National Institutes of Health, United States
- Prof Edward Katangole Mbidde Uganda Virus Research Institute (UVRI), Uganda
- Prof Leo J. Kinlen University of Oxford, United Kingdom
- Prof Andrei Kozlov St Petersburg State University, Russian Federation
- Dr Simon Lacey Beckman Research Institute of the City of Hope, United States
- Dr Lucia Lopalco San Raffaele Scientific Institute, Italy
- Prof Alberto Mantovani University of Milan, Italy
- Dr Francesco Marincola Immunogenetic section, National Institutes of Health, United States
- Dr David R Milich Vaccine Research Institute of San Diego, United States
- Prof Jay Nelson Oregon Health & Sciences University, United States
- Prof Joseph S Pagano University of North Carolina, United States
- Prof Giorgio Palu' University of Padua, Italy
- Prof Yvonne Paterson University of Pennsylvania, United States
- Prof C. David Pauza University of Maryland School of Medicine, United States of America
- Dr Maurizio Provenzano University Hospital of Zurich, Switzerland
- Prof Thomas Schulz University of Hannover, Germany
- Prof Worachart Sirawaraporn Mahidol University, Thailand
- Prof Freddy Sitas The Cancer Council, New South Wales, Australia
- Prof Freda Stevenson University of Southampton, United Kingdom
- Prof Maria Caterina Turco University of Salerno, Italy
- Prof Huang Wenlin Sun Yat-sen University, China
- Prof Hans Wolf University of Regensburg, Germany
- Dr Robert Yarchoan HIV and AIDS Malignancy Branch, National Institutes of Health, United States
- Dr John Ziegler University of California, San Fransisco, United States
Advisory Board
- Prof Peter Biberfeld Karolinska Institute, Sweden
- Prof Luigi Chieco-Bianchi University of Padova, Italy
- Prof Guy G de The Epidemiology of oncogenic viruses, Institut Pasteur, France, France
- Prof Robert Gallo University of Maryland, United States
- Prof Eva Klein Karolinska Institute, Sweden
- Prof Reinhard Kurth Robert Koch-Instituts, Germany
- Prof Bernard Roizman University of Chicago, United States
- Prof Robin Weiss University College London, United Kingdom
- Harald zur Hausen German Cancer Research Center, Germany
